chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Suspected vaccination failure; shingles in ear; shingles; burning in my ear; earache; blisters on my face and the lower part of my back; This case was reported by a consumer and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. In April 2021, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), herpes zoster otitis externa (serious criteria GSK medically significant), shingles, burning sensation, ear pain and blister. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the herpes zoster otitis externa, shingles, burning sensation, ear pain and blister were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, herpes zoster otitis externa, shingles, burning sensation, ear pain and blister to be related to Shingles vaccine.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The age group was not reported but was captured as adult as per vaccine indication. A week before the date of reporting, the patient experienced burning in ear and thought it was earache and went to physician who said it was shingles. At the time of reporting the patient was having blisters on face and lower part of back. This case was considered to be a suspected vaccination failure case, as the details regarding completion of primary vaccination schedule, laboratory confirmation for shingles and time to onset were unknown.
27OCT91 t103-104 seen by MD on 28OCT91 was told severe rxn to MMR had t103 x 3 days was afebrile x 24 hrs then t103 again; Seen by MD 1NOV91, was told bronchitis; had nasal congestion, cough, h/a, & muscle aches all wk;
Cough from bad lung irritation. Keep bring up mucous, also headache and weakness still not better.
Headache, Myalgia, Arthralgia, Fever, NauseaVomiting, Injection site sore,reddness and swelling. C/O fatigue,light sensentivity. Told to follow up with primary care physician Narrative:
c/o sneezing-coughing & SOB 1 hr p/vax; sent to clinic for eval; pulmonary function, CXR-breathing tx;
monday  - pt was given flu shot tuesday - pt awaken with swollen face and top lip         - dr was called and dr prescribed benadryl wednesday - swelling continued and spreaded to bottom lip.  swelling was very very large. pt was taken to the emergency room.  Drs there started pt on a steroid for 7 days. Meds currently taking are : 1. Amiodarone   200mg 2. Metoprolol   100mg 3. Warfarin Sod  7.5mg 4. Triamterene  37.5mg 5. Monopril     40mg 6. Reminyl       8mg 7. Zyprexa     2.5mg 8. Levoxyl     0.25mg pt had also been taking aricept 5mg the prior week.  pt discontinued the use of aricept due to severe nausea.
Pt rec'd GARDASIL (initial injection) by nurse on 5/15/08 -> Pt called office following day approx 3 pm reported she developed rash on chest, arm, neck - 4 hrs after injections denied any other potential contact. Pt has some eczema (works around chemicals at beauty salon).
COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication were provided. No concomitant medication were provided.
swollen glands, sore throat, t100-101 for 3 days starting 3rd day p/vax; pt broke out in rash, raised patch; itching/burning eyes; achey feeling; lasted about 2 wks; very tired;
I started having severe allergies and they have not stopped as of today 21Jun2021; severe sinusitis; It began as a sore throat; developed into a chronic cough; sneezing; occasional weakness; This is a spontaneous report from a contactable consumer (patient). A 34-year-old male patient received the second dose of BNT162B2 (PFIZER COVID-19 VACCINE, lot number: EL3247), at the age of 34 years old, in left arm on 20Apr2021 17:00 at single dose for covid-19 immunisation. Medical history was none. The patient was not diagnosed with covid-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to vaccination. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously took aspartame and experienced drug allergy. The patient previously received the first dose of BNT162B2 (lot number: EL3247), at the age of 34 years old, in left arm on 30Mar2021 09:30 at single dose for covid-19 immunisation. On 01May2021 07:00, within 2 weeks of the second vaccine, the patient started having severe allergies and they had not stopped as of 21Jun2021. It began as a sore throat and developed into a chronic cough. Within a few weeks the patient was also experiencing severe sinusitis and sneezing. The patient also experienced occasional weakness. All symptoms had been somewhat managed through doctor provided and over-the-counter (OTC) medication. The patient had never had to deal with seasonal or other allergies before. The patient had been tested for covid-19 since the vaccination. The patient underwent lab tests and procedures which included SARS-COV-2 RNA, QL, RT, PCR (covid-19) test (nasal swab) negative on 11May2021. Therapeutic measures were taken as a result of the event severe allergies and included treatment with prescription medication. The outcome of event was not recovered.  No follow-up attempts are possible. No further information is expected.
She received her vaccine and proceeded to a site care instruction area. She immediately c/o not feeling well. She was taken to an exam room and collapsed on the way. She began to c/o her throat and mouth itching. B/P 142/88, pulse 80 and regular. Benadryl 50 mg IM administered, followed by epinephrine .3 cc IM.(10:30 a.m.) At 10:40 a.m., patient continued to c/o throat itching. Epinephrine .2 cc IM was administered. B/P 136/80, pulse 64, blood glucose 76. Patient transported to emergency room where she was evaluated and observed. Further doses of benadryl were given. She was discharged to home after two hours, with oral benadryl. 24 hour follow-up: Vaccination site is a bright red circle, 2 cm in diameter. C/o feeling weak with episodes of feeling hot; having a generalized tingling sensation; and an itchy throat. Follow up with reporting person today (02/26/2003) shows pt with complete recovery and no further adverse events  Per 60 day follow up: pt has recovered.
Following the vax, the pt experienced a "tingly/prickly" feeling on the bottom of his feet which worsened after exercise or jogging.  The reporting physician felt that the pt's symptoms were not related to the vaccine. As of 11/13/00, the outcome of the event is unknown.
I had a left eye infection and left sinus infection lasting 3 weeks. I went in  to the doctor 7/26 gave me Cefdinir 300 mg capsule 1 every 12 hrs 10 days, Erythromycin for eye 3 times daily and Suphedrine PE 2 tablets 3 times daily.
Woke up with all the symptoms; chills, fever of 101.5, headache, bodyaches, fatigue. I took Tylenol extra strength to help with symptoms. Headache persisted. Symptoms lasted until late night the next day.
Itchy, red rash on neck and chest; Itchy, red rash on neck and chest; swollen lymph node on left side near ear; This is a spontaneous report from a non-contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8753) via an unspecified route of administration in the left arm on 28Apr2021 at 15:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes, hyperlipemia, hypertension and COVID-19. The patient previously had strawberries and experienced fruit allergy; she also had peanut butter and experienced food allergy. Concomitant medications taken within two weeks of vaccination included metformin 1000 milligram (MANUFACTURER UNKNOWN), hydrochlorothiazide 12.5 milligram (MANUFACTURER UNKNOWN) and dapagliflozin propanediol monohydrate (FARXIGA); all from unknown date for unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 06Apr2021 at 11:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 at 07:00, the patient experienced itchy, red rash on neck and chest, swollen lymph node on left side near ear. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events itchy, red rash on neck and chest, swollen lymph node on left side near ear was resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.
Shingles out break -- appeared 10 days after the vaccine; This is a spontaneous report from a contactable consumer or other non-healthcare professional (patient reported for herself). A 39-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: FC3184), first dose via an unspecified route of administration, administered in left arm on 11Sep2021 at 11:00 (at the age of 39-year-old) as dose 1, single for COVID-19 immunisation at pharmacy or drug store. Medical history included breast cancer female from an unknown date and unknown if ongoing in remission from Breast Cancer 3 years since no evidence of disease. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient did not diagnose with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. On 21Sep2021, the patient experienced shingles outbreak appeared 10 days after the vaccine (herpes zoster) (non-serious) with outcome of not recovered. The event had not resulted in for death, life-threatening, prolonged hospitalisation, disabling/incapacitating or Congenital anomaly/birth defect. Adverse event result in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of shingles outbreak appeared 10 days after the vaccine (herpes zoster) with Valtrex. The outcome of the event was reported as not resolved.  Follow-up attempts are completed. No further information is expected.
tight chest; difficulty breathing; Throwing up; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (tight chest), DYSPNOEA (difficulty breathing) and VOMITING (Throwing up) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concurrent medical conditions included Penicillin allergy.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced CHEST DISCOMFORT (tight chest), DYSPNOEA (difficulty breathing) and VOMITING (Throwing up). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, CHEST DISCOMFORT (tight chest), DYSPNOEA (difficulty breathing) and VOMITING (Throwing up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product included sometimes painkillers for her knee.
w/in 48hr had weakness in  measles of both arms;saw MD APR97 & referred to a neuro APR97 told pt it was from a virus in the flu shot;
1 of 4 linked same reporter cases (other related cases: 1210USA012785, 1210USA013663 and 1210USA013664). This spontaneous report as received from a pharmacist refers to unspecified number of patients who on unknown dates were vaccinated with RECOMBIVAX HB. The patients might have been vaccinated with improperly stored of RECOMBIVAX HB but did not have any other information. No adverse effects reported at that time. The outcome of the event was unknown. Additional information is not expected.
I received a call from pt, dob:5/14/55 on Thursday 10/16/08 at 1 pm, regarding an adverse reaction that occurred to her following an influenza vaccine injection on Monday 10/13/08 between 10:30 and 11:30 am. . The nurse on-site, had administered the vaccine between the hours of 10:30 and 11:30 and had left the clinic shortly after 11:30. Pt reported that she ate her lunch, at 11 am, it consisted of yogurt and fried chicken that she had brought with her from home that morning. Pt reported that at approximately 1 pm she became violently ill with vomiting, diarrhea, chills and shaking. She reported that she spiked a temp of 103 degrees farenheit. She reported 4 episodes of vomiting that continued into the evening. she remained at work until 4:30 pm at which time an associate offered to drive her home. She refused the offer and states "I drove herself home with much difficulty". She stated that she had dark circles under her eyes the following morning from dehydration. On Thursday at the time of report, she was feeling much better. She was offered an appointment with a physician. Pt refused the appointment. She reports that her family physician and Neurologist in the office where she is employed stated that she should not have received the flu shot due to recent illness. Pt stated that she was on her final day of antibiotics following an episode of pneumonia. She states that she reported the recent illness to the nurse administering the vaccine and was told by that nurse there was no problem with having the vaccine administered at that time. Pt completed and signed a standard on-site vaccine consent form prior to receiving the vaccine. Sanofi/Avenis vaccine lot #U2807AA. Please add an additional page if necessary.
This spontaneous report was received from a registered nurse regarding a 6 year old female patient. The patient's medical history, concurrent conditions, concomitant medication and drug reactions/allergies were not provided. On 23-MAY-2018, the patient was inadvertently vaccinated with GARDASIL 9 injection, intramuscularly, 0.5 mL once, lot # N021571 with expiration date 29-MAY-2020, for prophylaxis (anatomical location were not provided). No adverse effects were reported. The patient was doing fine then, did not seek medical attention or received treatment.
This spontaneous report was received from a registered nurse refers to a teenager female patient. On an unknown date, the patient was vaccinated with (Merck) VARIVAX (dose, route and lot number were not provided). On an unknown date, the patient who received (Merck) VARIVAX in the past (unspecified number of doses) had developed chickenpox. The outcome of chickenpox was reported as recovered on unspecific date. The event of chickenpox was unknown related to (Merck) VARIVAX. Additional information is not expected.
17 year old received received SHINGRIX; received Shingrix instead of Meningitis vaccination; This case was reported by a other health professional and described the occurrence of inappropriate age at vaccine administration in a 17-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown.  Additional details were provided as follows: The other health professional reported that 17 year old patient had received Shingrix instead of Meningitis vaccination, which led to inappropriate age at vaccine administration and wrong vaccine administered. No further details were provided at the time of the call.  The reporter consented to follow up. This case was linked with US2021214420, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021214420:same reporter
No adverse effects were reported; improperly stored vaccines; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information was given regarding the patient's concurrent conditions, concomitant medications or medical history.  On 04-NOV-2019 or on 05-NOV-2019, the patient was vaccinated with an improper stored haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB) lot # S000352 with expiration 17-OCT-2021 for prophylaxis (dose and route of administration were not reported). The administered dose of the vaccine experienced a temperature excursion of lowest temperature below 36°F/2 degrees Celsius (1.3C) for 2 hours 18 minutes with no previous temperature excursion.  There was no adverse effect reported.  This call was because of a data logger.  This is one of two reports from the same reporter.
Caregiver states onset pain to arm, neck, shoulder one day after vaccine.  States flu-like symptoms one day after but resolved.
Patient states that the next day, she experienced lip tingling and her lips swelled. She was treated with a Medrol dosepak and Benadryl and it resolved. She was at a doctor's appt when reaction occurred. (Patient did mention that a few months previous, she did receive Juvederm, a lip filler, but had no issues with it).
Bronchospastic cough that persisted for 2 weeks, worse at night. No other symptoms - gave 5 day course of 1mg/kg steroid.
Was unknowingly asymptomatic COVID positive at time of Pfizer booster. / COVID symptoms became moderate severe; Dose 1: Moderna, Dose 2: Moderna; Dose 1: Moderna, Dose 2: Moderna; booster injection; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 26 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 22Nov2021 (Lot number: 2122FJ1611) at the age of 26 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Moderna (Dose Number: 2, Batch/Lot No: 039A21A), for Covid-19 immunization; Moderna (Dose Number: 1, Batch/Lot No: 048A21A), for Covid-19 immunization. The following information was reported: OFF LABEL USE (non-serious), INTERCHANGE OF VACCINE PRODUCTS (non-serious) all with onset 22Nov2021, outcome "unknown" and all described as "Dose 1: Moderna, Dose 2: Moderna"; IMMUNISATION (non-serious) with onset 22Nov2021, outcome "unknown", described as "booster injection"; COVID-19 (non-serious) with onset 24Nov2021, outcome "recovering", described as "Was unknowingly asymptomatic COVID positive at time of Pfizer booster. / COVID symptoms became moderate severe". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (24Nov2021) positive. Therapeutic measures were not taken as a result of covid-19.  Additional information :No other vaccine in four weeks. Patient was unknowingly asymptomatic COVID positive at time of Pfizer booster. After booster injection,COVID symptoms became moderate -severe and have lasted 7+ days. No covid prior vaccination. Patient was covid tested post vaccination.
A 42-year-old female patient, with no reported medical history, received a left arm intramuscular injection of FLUZONE SV 2009-2010 (lot number U3186AA) on 11 September 2009. The day after vaccination, she developed itchy bumps on her face and neck. She also reported "acting confused" the night after vaccination. The patient reported that she was no longer confused, but the itchy bumps were ongoing. She noted that she had received FLUZONE injections for many years.
feels sick to her stomach; arm pain, can't even touch it; upset stomach; arm  is very sore; chills; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (feels sick to her stomach), PAIN IN EXTREMITY (arm pain, can't even touch it), ABDOMINAL DISCOMFORT (upset stomach), MYALGIA (arm  is very sore) and CHILLS (chills) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 058H21A, 015M20A and 029L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Dec-2021, the patient experienced ILLNESS (feels sick to her stomach), PAIN IN EXTREMITY (arm pain, can't even touch it), ABDOMINAL DISCOMFORT (upset stomach), MYALGIA (arm  is very sore) and CHILLS (chills). At the time of the report, ILLNESS (feels sick to her stomach), PAIN IN EXTREMITY (arm pain, can't even touch it), ABDOMINAL DISCOMFORT (upset stomach), MYALGIA (arm  is very sore) and CHILLS (chills) outcome was unknown.            No concomitant medications were reported No treatment medications were reported   Most recent FOLLOW-UP information incorporated above includes: On 02-Dec-2021: Non significant follow up received, contains No new information
pt recvd vax 24NOV95 & was sleeping w/father & found pulseless & unresponsive;brought to ER & pronounced dead;autopsy done conclusion accidental suffocation as COD